Stay updated on CAR-T Cell Therapy in Heme Malignancies Clinical Trial
Sign up to get notified when there's something new on the CAR-T Cell Therapy in Heme Malignancies Clinical Trial page.

Latest updates to the CAR-T Cell Therapy in Heme Malignancies Clinical Trial page
- Check4 days agoChange DetectedA site-wide notice about a lapse in government funding was added and the page now shows Revision: v3.4.1, replacing the previous v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check11 days agoChange DetectedThe updates on 2026-01-23 are cosmetic UI and documentation changes to the history display, including a Results Posted indicator and color-coding notes for additions and deletions, and they do not modify underlying study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference2%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedNew version v3.3.4 was returned on 2026-01-06, adding core trial sections such as Study Design, Study Status, Outcome Measures, Adverse Events, Baseline Characteristics, and Participant Flow, along with related document sections. This update also replaces the previous revision v3.3.3.SummaryDifference1%

- Check46 days agoChange DetectedThe history now shows a new 'Results Submitted' entry and revision v3.3.3; the previous 'No Results Posted' note and the 'HHS Vulnerability Disclosure' reference, along with the prior revision v3.3.2, were removed.SummaryDifference0.3%

- Check75 days agoChange DetectedThe study record history shows an addition of revision v3.3.2 and removal of v3.2.0, reflecting maintenance of the historical record. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check82 days agoChange DetectedDeleted a site-wide notice about government funding and operating status, which does not affect the study data, eligibility, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

Stay in the know with updates to CAR-T Cell Therapy in Heme Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CAR-T Cell Therapy in Heme Malignancies Clinical Trial page.